Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia

Affiliations

• ¹ Medical Biology Department, Robert Ballanger Hospital, Aulnay-Sous-Bois, France. angelique.grenier@ght-gpne.fr.
• ² Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France.
• ³ University of Paris, Imagine Institute, Paris, France.
• ⁴ St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
• ⁵ Howard Hughes Medical Institute, New York, NY, USA.
• ⁶ Department of Internal Medicine, Robert Ballanger Hospital, Aulnay-Sous-Bois, France.